The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on August 9, 2023. The analyst firm set a price target for $7.00 expecting PHGE to rise to within 12 months (a possible 1901.14% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for BiomX (AMEX: PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $0.00 to $7.00. The current price BiomX (PHGE) is trading at is $0.35, which is within the analyst’s predicted range.

The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on August 9, 2023. The analyst firm set a price target for $7.00 expecting PHGE to rise to within 12 months (a possible 1901.14% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for BiomX (AMEX: PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $0.00 to $7.00. The current price BiomX (PHGE) is trading at is $0.35, which is within the analyst’s predicted range.

The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on August 9, 2023. The analyst firm set a price target for $7.00 expecting PHGE to rise to within 12 months (a possible 1901.14% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for BiomX (AMEX: PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $0.00 to $7.00. The current price BiomX (PHGE) is trading at is $0.35, which is within the analyst’s predicted range.

The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on August 9, 2023. The analyst firm set a price target for $7.00 expecting PHGE to rise to within 12 months (a possible 1901.14% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for BiomX (AMEX: PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $0.00 to $7.00. The current price BiomX (PHGE) is trading at is $0.35, which is within the analyst’s predicted range.

The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on August 9, 2023. The analyst firm set a price target for $7.00 expecting PHGE to rise to within 12 months (a possible 1901.14% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for BiomX (AMEX: PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $0.00 to $7.00. The current price BiomX (PHGE) is trading at is $0.35, which is within the analyst’s predicted range.

The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on August 9, 2023. The analyst firm set a price target for $7.00 expecting PHGE to rise to within 12 months (a possible 1901.14% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for BiomX (AMEX: PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $0.00 to $7.00. The current price BiomX (PHGE) is trading at is $0.35, which is within the analyst’s predicted range.

The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on August 9, 2023. The analyst firm set a price target for $7.00 expecting PHGE to rise to within 12 months (a possible 1901.14% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for BiomX (AMEX: PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $0.00 to $7.00. The current price BiomX (PHGE) is trading at is $0.35, which is within the analyst’s predicted range.

The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on August 9, 2023. The analyst firm set a price target for $7.00 expecting PHGE to rise to within 12 months (a possible 1901.14% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for BiomX (AMEX: PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $0.00 to $7.00. The current price BiomX (PHGE) is trading at is $0.35, which is within the analyst’s predicted range.